The proteolytic activity of MT4-MMP is required for its pro-angiogenic and pro-metastatic promoting effects

Lorin Host1, Alexandra Paye, Benoit Detry

  • 1Laboratory of Tumor and Developmental Biology, Groupe Interdisciplinaire de Génoprotéomique Appliquée-Cancer, GIGA-Cancer, University of Liege, Liège, Belgium.

Insights

The catalytic activity of membrane-type 4 matrix metalloprotease (MT4-MMP) drives breast cancer growth and metastasis. Inactivating MT4-MMP

Area of Science:

  • Oncology
  • Molecular Biology
  • Biochemistry

Background:

  • Membrane-type 4 matrix metalloprotease (MT4-MMP) is linked to breast adenocarcinoma progression and metastasis.
  • The precise mechanism, particularly the role of MT4-MMP's proteolytic activity, in promoting tumor growth and spread remains unclear.

Purpose of the Study:

  • To investigate whether the pro-tumorigenic and pro-metastatic effects of MT4-MMP are dependent on its catalytic activity.
  • To elucidate the contribution of tumor-derived versus host-derived MT4-MMP in angiogenesis and tumor promotion.

Main Methods:

  • Site-directed mutagenesis was employed to inactivate MT4-MMP by substituting Glutamic acid 249 with Alanine in the active site.
  • Tumor growth, lung metastasis, and angiogenesis were assessed in vivo using genetically modified mice (recombination activating gene-1-deficient and MT4-MMP-deficient).
  • The requirement for a permissive microenvironment, including host angio-promoting factors like plasminogen activator inhibitor-1, was evaluated.

Main Results:

  • Active MT4-MMP significantly accelerated tumor growth and lung metastasis, alongside triggering an angiogenic switch.
  • These pro-tumorigenic effects were completely abolished upon MT4-MMP inactivation, highlighting the importance of its catalytic activity.
  • Tumor-derived MT4-MMP, not host-derived MT4-MMP, was found to contribute to angiogenesis, though it required host factors like PAI-1 to promote tumors.

Conclusions:

  • The catalytic activity of MT4-MMP within the tumor compartment is crucial for stimulating tumor growth and metastasis.
  • MT4-MMP acts as an intrinsic tumor cell determinant that shapes a permissive microenvironment conducive to cancer dissemination.
  • Targeting MT4-MMP's proteolytic function represents a potential therapeutic strategy for breast cancer.

Related Concept Videos

Role of Matrix Metalloproteases in Degradation of ECM01:23

Role of Matrix Metalloproteases in Degradation of ECM

Matrix metalloproteases (MMPs) are enzymes involved in the hydrolysis of proteins and glycoproteins of the extracellular matrix. MMPs are essential for the migration and proliferation of cells through the dense matrix network, throughout embryonic development, and throughout morphogenesis. The first MMP activity discovered was a collagenase in a tadpole's tail undergoing metamorphosis. The active collagen deposition and modifications lead to the morphogenesis of tadpoles into the adult body.
A...
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a rapamycin-insensitive companion...
Translocation of Proteins into the Mitochondria01:19

Translocation of Proteins into the Mitochondria

Mitochondrial precursors are translocated to the internal subcompartments via independent mechanisms involving distinct protein machineries called translocases.
Sorting of outer membrane proteins:
Mitochondrial outer membrane proteins are of two types: the transmembrane, beta-barrel porins, and the membrane-anchored, alpha-helical proteins. Beta-barrel porin precursors are translocated by the TOM complex and inserted into the outer mitochondrial membrane by the SAM complex. In contrast,...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
Regulation of Angiogenesis and Blood Supply01:24

Regulation of Angiogenesis and Blood Supply

Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits.  Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl hydroxylase and factor...
Microtubule Associated Proteins (MAPs)01:42

Microtubule Associated Proteins (MAPs)

Microtubule function and architecture are regulated by an array of specialized proteins called microtubule-associated proteins or MAPs. These proteins are widespread across different organisms and have conserved protein motifs, like the multi-TOG domain for tubulin binding found in the CLASP family of MAPs. Some MAPs are lineage-specific based on their conserved domains. Their functions depend upon the cytoskeletal architecture and cell type they are located within. In-plant cells, a specific...